Curis Lifesciences P/B Ratio
Current P/B Ratio
2.29
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Curis Lifesciences (CURIS) P/B ratio is 2.29 (Moderate), book value per share ₹58.75 vs Healthcare average P/B of -0.35 — High - Premium to book value, growth expectations or asset-light model. Compare with Curis Lifesciences value estimation to assess whether the stock is under or overvalued.
Current Valuation Metrics
P/B Ratio
2.29
Current Price
₹
Book Value/Share
₹58.75
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹47 Cr
Share Capital
₹8 Cr
Reserves & Surplus
₹39 Cr
Outstanding Shares
8,000,000
Book Value per Share
₹58.75
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.35
Sector Median
0.61
Sector Rank
#11 of 50
Sector Percentile
22.0%
CURIS P/B Ratio — Valuation Insights & Book Value Analysis
Curis Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 2.29 (Moderate). View CURIS annual price range for the annual high/low range and current price position.
- Trading at premium to sector average PB of -0.35
CURIS vs Healthcare Peers — P/B Ratio Comparison
Curis Lifesciences P/B 2.29 vs Healthcare average -0.35, median 0.61 — range -18.41–1.11.
Sector Average
-0.35
Sector Median
0.61
Lowest P/B
-18.41
Highest P/B
1.11
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |